You searched for "selection"

1072 results found

Supporting Patients Receiving Hormone Therapy: Introducing LiveWell

Androgen deprivation therapy (ADT) is a cornerstone of prostate cancer treatment, yet up to 30% of men experience significant long-term side effects affecting physical, metabolic, and psychological wellbeing. While there is strong evidence supporting exercise, lifestyle, and psychosocial interventions, access...

Demanding cases or nightmares in endourology? May/Jun 2016

In the third article in this series the authors describe their experience with the very rare indications for laparoscopic stone surgery. Case 1 A 44-year-old woman presented with several months of malaise and right flank pain. A CT scan demonstrated...

What are the long-term outcomes of TOT and TVT procedures?

This is a systematic review between 2000 and 2016 evaluating the efficacy and safety of midurethral sling (MUS) procedures in women. Studies were included if the follow-up data was five years or more. Objective cure rates showed no significant difference...

Urinary Incontinence - Assessment, Treatment and Management

An estimated 3-5 million adults in UK have urinary incontinence and the NHS spends an estimated £80 million a year on Incontinence pads (NHS England, 2018). Often people who have urinary incontinence receive poor quality care that does not meet...

Outcomes of preserving the foreskin during distal hypospadias

Hypospadias surgery continues to tax the minds of paediatric urologists. Increasingly distal hypospadias surgery is becoming more and more conservative (in some cases, carrying out only foreskin reconstruction and leaving a mild hypospadias) and the role of foreskin reconstruction as...

Femeda Ltd Wins Prestigious Medilink Partnership with Academia Award

Partnership with Academia Award Winner: Femeda Ltd Femeda has committed to the first real world clinical trial for a consumer medical device globally to be run in Manchester. Femeda is extending the partnership with engagement of Phd students from the...

Femeda Ltd Wins Prestigious Medilink Partnership with Academia Award

Femeda has committed to the first real world clinical trial for a consumer medical device globally to be run in Manchester. Femeda is extending the partnership with engagement of Phd students from...

Campbell Walsh Wein Urology: 3-Volume Set (Campbell-Walsh Urology), 12th Edition

The 12th edition of the ‘Bible of Urology’ was a pleasure to review. The title has been changed to Campbell-Walsh-Wein Urology to honour Dr Alan Wein’s many years of dedicated chief editorship of this famous textbook. The current editor-in-chief, Alan...

ABC UK announces 2025 Nurse of the Year – Kathryn Chatterton

Action Bladder Cancer UK (ABC UK) is delighted to announce that the winner of the 2025 ABC UK Nurse of the Year award is Kathryn Chatterton, Bladder Cancer Advanced Nurse Practitioner / Cancer Nurse Specialist at Guy’s and St Thomas’...

Prostate cancer: Black men more likely to be diagnosed at later stages

Latest data shows Black men have higher rates of stage 3 or stage 4 prostate cancer diagnoses compared with white men. Black men diagnosed at a later stage in their 60s are 14% less likely to get NICE approved treatment...

Urology patient assessment – importance of holistic approach – new paradigm

Mild cognitive impairment (MCI) seems to affect 30% of the general population above 65 and its presence has a wide range of significance. This is a prospective single centre study to look at MCI in adult urological patients above 18...

Testicular cancer: management of stage I seminoma

Introduction Testicular cancer is the most frequently occurring solid tumour in men between the ages of 15 and 34 years [1]. About 60% of cases are seminomas and approximately 70-80% of them have, at presentation, clinical stage I disease. This...